Buprenorphine blocks withdrawal in morphine-dependent rat pups

Paediatric Anaesthesia

Volumn 14, Issue 8, 2004, Pages 642-649

  Stoller, Dawn C ^a   Smith, Forrest L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Buprenorphine; Morphine; Opioid withdrawal; Rat

Indexed keywords

BUPRENORPHINE; MORPHINE; NALOXONE; SODIUM CHLORIDE;

ABDOMINAL WALL MUSCULATURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG INHIBITION; DRUG WITHDRAWAL; FEMALE; FOREFOOT; HINDLIMB; MALE; MORPHINE ADDICTION; MUSCLE STRETCHING; NEWBORN; NONHUMAN; OBSERVATION; OSMOTIC MINIPUMP; PRIORITY JOURNAL; PTOSIS; RAT; SINGLE DRUG DOSE; TIME; TREMOR; VOCALIZATION; WET DOG SHAKES; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; ANIMALS; BUPRENORPHINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MORPHINE; MORPHINE DEPENDENCE; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; TREATMENT OUTCOME;

EID: 4043079273     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2004.01264.x     Document Type: Article

References (32)

1. Arnold JH, Truog RD, Orav EJ et al. Tolerance and dependence in neonates sedated with fentanyl during extracorporeal membrane oxygenation. Anesthesiology 1990; 73: 1136-1140.
2. Tobias JD, Schleien CL, Haun SE. Methadone as treatment for iatrogenic narcotic dependency in pediatric intensive care patients. Crit Care Med 1990; 18: 1292-1293.
3. Franck LS, Vilardi J, Durand D et al. Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation. Am J Crit Care 1998; 7: 364-369.
4. Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet 1999; 353: 221-226.
5. Bickel WK, Stitzer ML, Liebson IA et al. A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts. Clin Pharmacol Ther 1988; 43: 72-78.
6. Bickel WK, Stitzer ML, Bigelow GE et al. Buprenorphine: dose related blockade of opioid challenge effects in opioid-dependent humans. J Pharmacol Exp Ther 1988; 247: 47-53.
7. Johnson RE, Jaffe JH, Fudala PJ. A controlled trial of buprenorphine treatment for opioid dependence. JAMA 1992; 267: 2750-2755.
8. West SL, O'Neal KK, Graham CW. A meta-analysis comparing the effectiveness of buprenorphine and methadone. J Subst Abuse 2000; 12: 405-414.
9. Cowan A, Lewis JW, MacFarlane IR. Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. Br J Pharmac 1977; 60: 537-545.
10. Lohmann AB, Smith FL. Buprenorphine substitution ameliorates spontaneous withdrawal in fentanyl-dependent rat pups. Pediatr Res 2001; 49: 50-55.
11. Jacob JC, Michaud GM, Tremblay EC. Mixed agonist-antagonist opiates and physical dependence. Br J Clin Pharmac 1979; 7: 291S-296S.
12. Thornton SR, Smith FL. Characterization of neonatal rat fentanyl tolerance and dependence. J Pharmacol Exp Therap 1997; 281: 514-521.
13. Thornton SR, Smith FL. Long-term alterations in opioid antinociception resulting from infant fentanyl tolerance and dependence. Eur J Pharmacol 1998; 363: 113-119.
14. Stoller DC, Thornton SR, Smith FL. Loss in efficacy in fat pups infused with morphine from osmotic minipumps. Pharmacology 2002; 66: 11-18.
15. Thornton SR, Wang AK, Smith FL. Characterization of neonatal rat morphine tolerance and dependence. Eur J Pharmacol 1997; 340: 161-167.
16. Ruiz F, Fournie-Zaluski MC, Roques BP et al. Similar decrease in spontaneous morphine abstinence by methadone and RB 101, and inhibitor of enkephalin catabolism. Br J Pharmacol 1996; 119, 174-182.
17. Garrido MJ, Jiminez R, Gomez E et al. Influence of plasma-protein binding on analgesic effect of methadone in rats with spontaneous withdrawal. J Pharm Pharmacol 1996; 48: 281-384.
18. Ohtani M, Kotaki H, Sawada Y et al. Comparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic pharmacodynamic modeling. J Pharmacol Exp Ther 1995; 272: 505-510.
19. Hambrook JM, Rance MJ. The interaction of buprenorphine with the opiate receptor: lipophilicity as a determining factor in drug-receptor kinetics. In: Kosterlitz HW, ed. Opiates and Endogenous Opioid Peptides. Amsterdam, North-Holland Pub. Co.; 1976: 295-301.
20. Bullingham RE, McQuay HJ, Moore A et al. Buprenorphine kinetics. Clin Pharmacol Ther 1980; 28: 667-672.
21. Barrett DA, Simpson J, Rutter N et al. The pharmacokinetics and physiological effects of buprenorphine infusion in premature neonates. Br J Clin Pharmacol 1993; 36: 215-219.
22. Fudala PJ, Jaffe JH, Dax EM et al. Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal. Clin Pharmacol Ther 1990; 47: 525-534.
23. Amass L, Bickel WK, Higgins ST et al. Alternate-day dosing during buprenorphine treatment of opioid dependence. Life Sci 1994; 54: 1215-1228.
24. Matthes HWD, Maldonado R, Simonin F et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid receptor gene. Nature 1996; 383: 819-823.
25. McPhie AA, Barr GA. The role of opioid receptors in morphine withdrawal in the infant rat. Dev Brain Res 2000; 124: 73-80.
26. Bonci A, Williams JT. Increased probability of GABA release during withdrawal from morphine. J Neurosci 1997; 17: 796-803.
27. Chieng B, Williams JT. Increased opioid inhibition of GABA release in nucleus accumbens during morphine withdrawal. J Neurosci 1998; 18: 7033-7039.
28. Keith DE, Murray SR, Zaki PA et al. Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem 1996; 271: 19021-19024.
29. Keith DE, Anton B, Murray SR et al. Mu opioid receptor internalization: opiate drugs have differential effects on conserved endocytic mechanism in vitro and in the mammalian brain. Mol Pharmacol 1998; 53: 377-384.
30. Finn AK, Whistler JL. Endocytosis of the mu-opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal. Neuron 2001; 32: 829-839.
31. Belcheva MM, Jacob B, McHale RJ et al. Differential downregulation and upregularion of rat brain opioid receptor types and subtypes by buprenorphine. Mol Pharmacol 1993; 44: 173-179.
32. Mello NK, Mendelson JH. Buprenorphine suppresses heroin use by heroin addicts. Science 1980; 207: 657-659.